MedTrace Logo

Post Marketing Surveillance To Observe Safety And Efficacy Of Duavive

NCT02792504 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 669

Last updated 2021-08-05

Study results available
· View outcomes & findings →

Summary

To evaluate safety and efficacy of CE/BZA in real practice in Korea

Conditions

  • Severe Vasomotor Symptom Associated With Menopause

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
20 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-29
Primary Completion
2020-07-22
Completion
2020-07-22

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02792504 on ClinicalTrials.gov